These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25435205)

  • 21. Controversies in ASSAY and drug development technologies: a focus on assessing irreproducibility.
    Glickman JF; Lundbäck T; Napper AD; Niles WD; Simeonov A; Weaver CD; Yin HH; Zaman GJ; Osada H
    Assay Drug Dev Technol; 2014 Oct; 12(8):443-51. PubMed ID: 25383720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Challenges and prospects for drug development of molecular targeting agents in Japan].
    Iwasaki M
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():695-702. PubMed ID: 23513923
    [No Abstract]   [Full Text] [Related]  

  • 23. NIPTE: a multi-university partnership supporting academic drug development.
    Gurvich VJ; Byrn SR
    Drug Discov Today; 2013 Oct; 18(19-20):916-21. PubMed ID: 23732177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anecdotes from ITMAT: building capacity for translational science.
    FitzGerald GA
    Clin Pharmacol Ther; 2013 Sep; 94(3):291-6. PubMed ID: 23963214
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing risks in drug discovery: reproducibility of published findings.
    Kannt A; Wieland T
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):353-60. PubMed ID: 26883784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in the Development of Novel Cardiovascular Therapies.
    Hwang TJ; Kesselheim AS
    Clin Pharmacol Ther; 2017 Aug; 102(2):194-196. PubMed ID: 28643861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Q&A: Perry Nisen. Better insights, better drugs.
    Nisen P; Bender E
    Nature; 2015 Nov; 527(7576):S18. PubMed ID: 26536220
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulatory Science - An Underappreciated Component of Translational Research.
    Rouse R; Zineh I; Strauss DG
    Trends Pharmacol Sci; 2018 Mar; 39(3):225-229. PubMed ID: 29329784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translational bioinformatics: data-driven drug discovery and development.
    Butte AJ; Ito S
    Clin Pharmacol Ther; 2012 Jun; 91(6):949-52. PubMed ID: 22609903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An incentive-based approach for improving data reproducibility.
    Rosenblatt M
    Sci Transl Med; 2016 Apr; 8(336):336ed5. PubMed ID: 27122610
    [No Abstract]   [Full Text] [Related]  

  • 31. Found in translation: integrated approaches to drug development.
    Doggrell SA
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):207-9. PubMed ID: 22115403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies?
    Potter BK
    Clin Orthop Relat Res; 2016 Apr; 474(4):892-4. PubMed ID: 26872915
    [No Abstract]   [Full Text] [Related]  

  • 33. Agreement of drug discovery data with Benford's law.
    Orita M; Hagiwara Y; Moritomo A; Tsunoyama K; Watanabe T; Ohno K
    Expert Opin Drug Discov; 2013 Jan; 8(1):1-5. PubMed ID: 23121309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biomarker is not the end.
    Nohaile M
    Drug Discov Today; 2011 Oct; 16(19-20):878-83. PubMed ID: 21888986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
    Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
    Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistics in the medical literature: 3.
    Altman DG
    Stat Med; 1999 Feb; 18(4):487-90. PubMed ID: 10070688
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug development: Raise standards for preclinical cancer research.
    Begley CG; Ellis LM
    Nature; 2012 Mar; 483(7391):531-3. PubMed ID: 22460880
    [No Abstract]   [Full Text] [Related]  

  • 38. The American Society of Clinical Oncology's Blueprint for Transforming Clinical and Translational Cancer Research.
    Meropol NJ; Kris MG; Winer EP
    J Clin Oncol; 2012 Mar; 30(7):690-1. PubMed ID: 22215747
    [No Abstract]   [Full Text] [Related]  

  • 39. Challenges facing the development of cancer vaccines.
    Fishman M
    Methods Mol Biol; 2014; 1139():543-53. PubMed ID: 24619703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer: Reshaping the cancer clinic.
    Schmidt C
    Nature; 2015 Nov; 527(7576):S10-1. PubMed ID: 26536216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.